A Randomized, Placebo-Controlled Trial of Three Fixed Dosages of Prolonged-Release OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder
- 1 May 2008
- journal article
- research article
- Published by Elsevier BV in Biological Psychiatry
- Vol. 63 (10), 981-989
- https://doi.org/10.1016/j.biopsych.2007.11.008
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorderThe British Journal of Psychiatry, 2007
- Efficacy of a Novel Biphasic Controlled-Release Methylphenidate Formula in Adults With Attention-Deficit/Hyperactivity DisorderThe Journal of Clinical Psychiatry, 2007
- Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatryThe British Journal of Psychiatry, 2007
- Long-acting medications for the hyperkinetic disordersEuropean Child & Adolescent Psychiatry, 2006
- A Randomized, Placebo-Controlled Trial of OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity DisorderBiological Psychiatry, 2006
- ADHD Drugs and Cardiovascular RiskNew England Journal of Medicine, 2006
- Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for PsychopharmacologyJournal of Psychopharmacology, 2006
- Patterns and Predictors of Attention-Deficit/Hyperactivity Disorder Persistence into Adulthood: Results from the National Comorbidity Survey ReplicationBiological Psychiatry, 2005
- A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorderBiological Psychiatry, 2005
- Meta-Analysis of the Efficacy of Methylphenidate for Treating Adult Attention-Deficit/Hyperactivity DisorderJournal of Clinical Psychopharmacology, 2004